Working… Menu
Trial record 13 of 365 for:    transthyretin

Screening for the Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy (TRAP2.1) (TRAP2-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01705626
Recruitment Status : Recruiting
First Posted : October 12, 2012
Last Update Posted : July 12, 2019
Information provided by (Responsible Party):
Centogene AG Rostock

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 28, 2020
Estimated Study Completion Date : April 30, 2020